AI brief of an SEC Form 8-K · National Healthcare (NHC)

NHC completes $560 million purchase of 35 NHI facilities

Neutral Impact 4 of 5 m&a Written later

NHC completed its purchase of the real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors for $560 million, ending a lease arrangement under which NHC had operated these facilities since a 1991 master lease. The company said it expects the ownership to be accretive to earnings and cash flow, but the filing gives no figures for that expectation. The deal was funded with $530 million of new borrowings, which adds to NHC's debt.

Key points

  • Purchase price of $560 million for real estate of 35 facilities (32 skilled nursing, 3 independent living), located in seven states
  • Drew the entire $475 million senior unsecured term loan and $55 million under the revolving credit facility on the closing date
  • Revolving credit facility increased from $50 million to $75 million under a First Amendment dated June 29, 2026; prior $50 million facility terminated with no outstanding borrowings
  • Four Florida skilled nursing facilities remain subject to a third-party operator's lease, which NHC has assumed under a subsidiary

The filing

CompanyNational Healthcare (NHC)
Form8-K, current report
Filed with the SECJul 1, 2026, 4:43 PM ET
Accession number0001437749-26-022306

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.01 Acquisition or Disposition Completed2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:39 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.